Use of healthcare resources in a cohort of rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs or tofacitinib
Jorge Enrique Machado‐Alba(Technological University of Pereira), N. Castaño Gamboa(Pfizer (United Kingdom)), Andrés Gaviria‐Mendoza(Technological University of Pereira), Juan Manuel Reyes, Manuel Enrique Machado‐Duque(Technological University of Pereira)
Cited by 9
Related Papers
Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2
|Communications Biology|2024|10
PCN210 RESOURCE UTILIZATION AND COST FOR WOMEN WITH ADVANCED HR+/HER2- BREAST CANCER IN COLOMBIAN HEALTH CARE SETTINGS
|Value in Health|2019|6
Budget Impact Analysis of Anticoagulation Clinics in Patients with Atrial Fibrillation under Chronic Therapy with Oral Anticoagulants
|Journal of Primary Care & Community Health|2021|3